172 related articles for article (PubMed ID: 9051097)
21. Prevalence of anti-hepatitis C virus in the blood donor population of Rio de Janeiro.
Vanderborght BO; Reis AM; Rouzere CD; da Silva RS; Yoshida CF; Franco LG; Maertens G; Van Heuverswijn H; Moreira Pereira J
Vox Sang; 1993; 65(2):122-5. PubMed ID: 7692672
[TBL] [Abstract][Full Text] [Related]
22. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
Ali N; Moiz B; Moatter T; Ahmed S; Adil SN; Khurshid M
Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507
[TBL] [Abstract][Full Text] [Related]
23. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
[TBL] [Abstract][Full Text] [Related]
24. Post-transfusion hepatitis revisited.
Ismay SL; Thomas S; Fellows A; Keller A; Kenrick KG; Archer GT; Wylie BR; Cossart YE
Med J Aust; 1995 Jul; 163(2):74-7. PubMed ID: 7542359
[TBL] [Abstract][Full Text] [Related]
25. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
[TBL] [Abstract][Full Text] [Related]
26. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
[TBL] [Abstract][Full Text] [Related]
27. A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese.
Lin CK; Chu R; Li KB; Leong S
Vox Sang; 1992; 62(2):98-101. PubMed ID: 1325715
[TBL] [Abstract][Full Text] [Related]
28. Frequency of hepatitis C viral RNA in anti-hepatitis C virus non- reactive blood donors with normal alanine aminotransferase.
Ali N; Moinuddin ; Ahmed SA; Chotani RA; Fisher-Hoch SP
J Coll Physicians Surg Pak; 2010 Oct; 20(10):662-6. PubMed ID: 20943108
[TBL] [Abstract][Full Text] [Related]
29. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
30. Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors.
Tsai JF; Jeng JE; Ho MS; Wang CS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Liver; 1997 Feb; 17(1):24-9. PubMed ID: 9062876
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels.
Björkman P; Sundström G; Widell A
Transfusion; 1998 Apr; 38(4):378-84. PubMed ID: 9595021
[TBL] [Abstract][Full Text] [Related]
32. Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase.
Sankary TM; Yang G; Romeo JM; Ulrich PP; Busch MP; Rawal BD; Vyas GN
Transfusion; 1994 Aug; 34(8):656-60. PubMed ID: 8073480
[TBL] [Abstract][Full Text] [Related]
33. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L.
Notari EP; Orton SL; Cable RG; Grindon AJ; Lenes BA; Williams AE; McMillan KM; Trouern-Trend JJ; Wolf-Nugent JS; Xu YL; Dodd RY;
Transfusion; 2001 Jun; 41(6):751-5. PubMed ID: 11399814
[TBL] [Abstract][Full Text] [Related]
35. Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
Makris K; Kouvelis V; Drakopoulos I; Oikonomou E; Maniatis A
Transfus Med; 1995 Sep; 5(3):213-24. PubMed ID: 8593527
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.
Romeo R; Thiers V; Driss F; Berthelot P; Nalpas B; Brechot C
Transfusion; 1993 Aug; 33(8):629-33. PubMed ID: 7688157
[TBL] [Abstract][Full Text] [Related]
37. Biochemical, virological and histopathological changes in Danish blood donors with antibodies to hepatitis C virus.
Grønbaek KE; Jensen OJ; Krarup HB; Dietrichson O
Dan Med Bull; 1996 Apr; 43(2):186-8. PubMed ID: 8741210
[TBL] [Abstract][Full Text] [Related]
38. The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China.
Wang M; He M; Wu B; Ke L; Han T; Wang J; Shan H; Ness P; Guo N; Liu Y; Nelson KE
Transfusion; 2017 Feb; 57(2):273-279. PubMed ID: 28194856
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
[TBL] [Abstract][Full Text] [Related]
40. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients.
Vrielink H; Reesink HW; van den Burg PJ; Zaaijer HL; Cuypers HT; Lelie PN; van der Poel CL
Transfusion; 1997 Aug; 37(8):845-9. PubMed ID: 9280331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
